On the digitalisation of biology and the Law of Accelerating Returns. Scaling-up Chrysea
Published at
We discuss Chrysea’s future, both in terms of scaling the business, developing its polyamine products, their relations to aging and how through the digitalisation of biology the company is addressing a gap in the healthspan and wellness industries.
In the second part of this interview, it discusses Chrysea’s future, both in terms of scaling the business, developing its polyamine products, their relations to aging and how through the digitalisation of biology the company is addressing a gap in the healthspan and wellness industries.